Cellectis (CLLS) Assets Average (2014 - 2026)

Cellectis' (CLLS) quarterly Assets Average came in at $307.0 million in Q1 2026, down 17.89% year-on-year from $373.8 million in Q1 2025, and down 8.07% quarter-over-quarter from $333.9 million in Q4 2025.

Cellectis (CLLS) Assets Average (2014 - 2026) Analysis & Trends

Cellectis' Assets Average history runs 13 years deep, the most recent figure standing at $307.0 million for Q1 2026.

  • On a quarterly basis, Assets Average fell 17.89% year-over-year to $307.0 million in Q1 2026; TTM through Mar 2026 was $307.0 million, a 17.89% decrease from a year earlier, with the FY2025 full-year figure at $354.1 million, down 1.33% from the prior year.
  • Assets Average eased to $307.0 million in Q1 2026 per CLLS's latest filing, from $333.9 million in the prior quarter.
  • Across five years, Assets Average topped out at $401.5 million in Q3 2024 and bottomed at $218.7 million in Q3 2023.
  • The 5-year median for Assets Average is $334.0 million (2022), against an average of $323.2 million.
  • Across the five-year window, Assets Average slumped 31.97% in 2022 and jumped 83.6% in 2024, its largest moves.
  • Year by year, Assets Average stood at $270.4 million in 2022, then advanced by 0.59% to $272.0 million in 2023, then surged by 43.28% to $389.7 million in 2024, then decreased by 14.33% to $333.9 million in 2025, then retreated by 8.07% to $307.0 million in 2026.
  • Per Business Quant, the three latest CLLS Assets Average figures stand at $307.0 million (Q1 2026), $333.9 million (Q4 2025), and $348.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 303.40 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 65.01 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 8.37 Bn
4 NuCana 279.75 Bn 279.75 Bn - 41.64 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 26.06 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 40.71 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 795.91 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.30 Bn
10 Cellectis 281.48 Mn 95.81 Mn - 306.95 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 306.95 Mn
Dec 31, 2025 333.88 Mn
Sep 30, 2025 348.51 Mn
Jun 30, 2025 359.03 Mn
Mar 31, 2025 373.82 Mn
Dec 31, 2024 389.71 Mn
Sep 30, 2024 401.51 Mn
Jun 30, 2024 380.80 Mn
Mar 31, 2024 344.36 Mn
Dec 31, 2023 271.99 Mn
Sep 30, 2023 218.69 Mn
Jun 30, 2023 239.54 Mn
Mar 31, 2023 256.31 Mn
Dec 31, 2022 270.40 Mn
Sep 30, 2022 300.23 Mn
Jun 30, 2022 334.04 Mn
Mar 31, 2022 364.63 Mn
Dec 31, 2021 397.48 Mn
Sep 30, 2021 435.23 Mn
Jun 30, 2021 450.14 Mn